Manes Taylor, Hedbany Davis, Patel Hursch, Okoro Sylvester, Anderson Michael, Gupta Nithin, Turnow Morgan, Beutel Bryan G
Department of Orthopaedic Surgery, OhioHealth Doctors Hospital, 5100 West Broad Street, Columbus, Ohio, United States.
SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY, United States.
J Hand Microsurg. 2025 Mar 1;17(3):100240. doi: 10.1016/j.jham.2025.100240. eCollection 2025 May.
Osteoarthritis (OA) of the first carpometacarpal (CMC) joint, or basilar thumb arthritis, is the most common symptomatic hand arthritis, leading to significant healthcare costs. This study analyzed trends in managing basilar thumb arthritis and determined approaches linked to favorable outcomes to guide future treatments.
This retrospective cohort study queried the TriNetX United States Collaborative Network from 2013 to 2023. Patients with primary OA of the first CMC joint were identified using International Classification of Diseases-10 codes, and surgical interventions were classified using Current Procedural Terminology codes. Patients were stratified by surgical status and age groups (18-59 years and 60 years or older). Baseline demographic characteristics, risk factors, and mortality rates were compared between surgical and non-surgical cohorts. The incidence and prevalence of surgical interventions for basilar thumb arthritis were also determined.
The study included 213,881 patients with primary basilar thumb arthritis (12,923 in the operative group and 195,820 in the non-operative cohort). Obesity (BMI 30-39), nicotine dependence, and Type 2 diabetes mellitus were more prevalent in the operative group (p < 0.01). The non-operative cohort had a lower average BMI (20-29, p = 0.04). Surgery incidence rose from 0.13 % in 2013 to 1.13 % by 2023, while prevalence increased from 0.45 % to 5.93 %. The matched odds ratios were 0.652 for 1-year, 0.763 for 3-year, and 0.818 for 5-year mortality.
Management of basilar thumb arthritis is shifting towards more surgical interventions. Identifying optimal patient profiles for surgery will refine management strategies for this condition.
第一腕掌(CMC)关节骨关节炎(OA),即基底节拇指关节炎,是最常见的有症状手部关节炎,导致高昂的医疗费用。本研究分析了基底节拇指关节炎的治疗趋势,并确定了与良好预后相关的方法,以指导未来的治疗。
这项回顾性队列研究查询了2013年至2023年的TriNetX美国协作网络。使用国际疾病分类第10版代码确定第一CMC关节原发性OA患者,并使用当前手术操作术语代码对手术干预进行分类。患者按手术状态和年龄组(18 - 59岁和60岁及以上)分层。比较手术组和非手术组的基线人口统计学特征、危险因素和死亡率。还确定了基底节拇指关节炎手术干预的发病率和患病率。
该研究纳入了213,881例原发性基底节拇指关节炎患者(手术组12,923例,非手术组195,820例)。肥胖(BMI 30 - 39)、尼古丁依赖和2型糖尿病在手术组中更为普遍(p < 0.01)。非手术组的平均BMI较低(20 - 29,p = 0.04)。手术发病率从2013年的0.13%上升到2023年的1.13%,而患病率从0.45%增加到5.93%。1年、3年和5年死亡率的匹配优势比分别为0.652、0.763和0.818。
基底节拇指关节炎的治疗正朝着更多的手术干预方向转变。确定手术的最佳患者特征将完善这种疾病的管理策略。